U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07853807) titled 'Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1' on Sept. 11.

Brief Summary: In Study 1, investigators will test the ability of each of the seven paradigms to differentiate between schizophrenia (SZ)/schizoaffective disorder (SZA) and matched healthy control subjects (HC) and to predict individual differences in clinical measures of hallucinations and delusions (as well as measures of function). Investigators will also directly compare the tasks in terms of predictive ability and psychometric properties and determine whether the tasks share variance or explain unique variance. This ...